Previous Article | Next Article ![]()
Molecular and Cellular Biology, May 2005, p. 3658-3669, Vol. 25, No. 9
0270-7306/05/$08.00+0 doi:10.1128/MCB.25.9.3658-3669.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Tsukuba Research Institute, Banyu Pharmaceutical Co., Ltd.,1 ERATO Environmental Response Project and Center for Tsukuba Advanced Research Alliance,2 Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan3
Received 23 August 2004/ Returned for modification 20 September 2004/ Accepted 28 January 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The Trsp gene, like all tRNA genes, is transcribed by RNA polymerase III. In general, tRNA gene transcription requires two promoter elements situated within their transcribed region, termed A and B boxes. In contrast, transcription of the Trsp gene relies on an internal B box and three upstream elements, a TATA motif, a proximal sequence element (PSE) and a distal sequence element (DSE) (5). Interestingly, the upstream promoter arrangement of the Trsp gene is shared with many small nuclear RNA and small nuclear RNA-type gene promoters (14).
Mutational analysis of the activator elements within the DSE region of the Trsp gene of Xenopus laevis identified a motif responsible for enhanced transcription called the SphI postoctamer homology (SPH) element (34). The protein factor that recognizes the SPH element was first characterized in Xenopus (41) and was termed selenocysteine tRNA gene transcription activating factor (Staf). In mouse, a single Staf protein has been found with similar DNA-binding specificity (1), whereas in human, two Staf-like proteins have been identified, an ortholog of Xenopus Staf referred to as ZNF143 and a related protein ZNF73 (33).
Herein we describe a conditional gene repair (CR) strategy in which the DSE is physically separated from the regulation of Trsp expression. Loss of DSE regulation over Trsp terminates mouse development beyond embryonic day 7.5 (E7.5), coupled to a substantial, although differential decrease in the transcript level of certain members of the selenoprotein family. From the analysis of targeted animals and cell based assays we define the DSE as a tissue-dependent activating element of Trsp expression that is essential for adequate tRNASec production during mouse embryogenesis.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Cell line transfection and primer extension assay. NIH 3T3 and Swiss-3T3 cell lines were grown in six-well dishes to a confluency of 60%. A total of 2 mg each of Trsp reporter plasmid (Fig. 1, lower panel) and Clontech pd2EGFP-N1 mammalian vector were transfected by using jetPEI solution (Funakoshi). Expression of tRNASec was evaluated as previously described (31) by using a primer complementary to bases 12 through 32 of the Trsp gene. A nucleotide exchange at position 9 in the Trsp transfection construct was used to distinguish the tRNASec product derived from the transfected plasmid and the wild-type Trsp gene product. Quantification of 18S rRNA was made by using a complementary primer to bases 618 to 639 5'-GAG CTG GAA TTA CCG CGG CTG-3', and enhanced green fluorescent protein (EGFP) quantification was performed by using the primer 5'-GCT CGA CCA GGA TGG GCA CCA-3' complementary to bases 699 to 719 of the EGFP mRNA product of the Clontech pd2EGFP-N1 mammalian vector.
|
|
|
All PCR genotyping of DNA from tail samples or embryos (at E9.5, E8.5, and E7.5) was performed for 35 cycles according to identical parameters (5 s at 94°C, 30 s at 65°C, and 30 s at 72°C). Wild-type and targeted alleles were distinguished by using the SeCKDCRFP1 primer in combination with SeCKDCRP1 or KDRP1 (Table 1), respectively. The presence of Cre recombinase was determined by using CreF and CreR primers, whereas the neomycin phosphotransferase gene was detected by using the Neo5-Prime and Neo3-Prime pair (Table 1).
Embryo whole-mount analyses. Decidual swellings dissected at E7.5 were fixed in 4% formaldehyde in phosphate-buffered saline (PBS) for 20 min at 4°C. Embryos were washed twice in PBS for 5 min each at room temperature and dissected in PBS.
RNase protection assay. The plasmid pBS:tRNASec-RNP-probe, consisting of the Bst1107I-HpaI Trsp fragment in pBluescript, was linearized by using Bst1107I and antisense tRNA with a specific activity of 4.7 x 107 cpm/µg produced by using the Ambion T7 Maxiscript kit. An 18S antisense probe, with a specific activity of 1.7 x 106 cpm/µg, was produced from the Ambion pTRI18S plasmid. Probes were gel purified and hybridized to 2.5 µg of total RNA overnight at 52°C. RNase digestions were allowed to occur for 25 min at room temperature by using a 1:300 dilution of RNase A/T1 mix. The protected fragments were resolved on a 10% denaturing polyacrylamide gel and detected by using a Fuji Bioimaging Analyzer BAS 2000.
cDNA cloning, recombinant GPX1 expression, and antibody production. Mouse Staf cDNA (Image 3661687) was purchased from Invitrogen. The cDNA for TR1 and DIO1 were amplified from the expressed sequence tag clones Ai048587 and Ai956288, respectively. cDNAs for GPX1, GPX4 and SelP were amplified by reverse transcription-PCR (RT-PCR) with total mouse liver RNA as the source of message. The primers and cDNA sequences used in their design are shown in Table 1. The amplified cDNAs were ligated into pCR-BluntII-TOPO (Invitrogen). To allow recombinant protein production of GPX1, the internal selenocysteine codon UGA had been exchanged to a cysteine UGU codon by using the primers GPX1SDMF and GPX1SDMR (Table 1). The coding region for GPX1 was subcloned into the NdeI and XhoI sites of the pET15b vector. Recombinant GPX1 was purified from soluble bacterial extracts by nickel chelate chromatography as described previously (23). The polyhistidine tag was removed by thrombin, and the protein further purified by hydroxyapatite column chromatography. Antibodies were raised in New Zealand White rabbits by MBL Japan, Ltd. For Western blotting, antisera to GPX1 were used at a 1:2,000 dilution.
RT-PCR analysis. Decidua were removed from 7.5-day-pregnant female mice, and maternal and extra-embryonic tissues were dissected from the embryo proper. Total RNA was reverse transcribed by using random hexamers, and the selenoprotein cDNA sequences were amplified by the primer pairs listed in Table 1. Real-time RT-PCR was performed to quantify GPX1, heme oxygenase I (HO-1), glutathione-S transferase (GST) A4, and NAD(P)H quinone oxidoreductase 1 (NQO1) mRNA levels by using an Applied Biosystems 7700 sequence detector.
RNA blotting analyses. Total RNA was size fractionated, transferred to nylon membranes, and probed by using radioactively labeled cDNA for Staf, GPX1, GPX4, TR1, SelP, and DIO1 retrieved from the pCR-BluntII-TOPO vectors described above. As a loading control the membrane was stained with methylene blue to visualize the 18S and 28S ribosomal bands.
Electrophoretic mobility shift assay. Adherent cell lines and mixed adherent or suspension cell lines were cultured on six-well plates, whereas suspension cell lines were grown in T75 flasks. Nuclei were prepared by using the Pierce NE-PER extraction kit containing Halt-II protease inhibitor according to the manufacturer's instructions. Gel retardation assays were performed in a total volume of 20 µl and contained 1 µg of nuclear extract, 1 µg of poly(dI-dC), and 1 ng of 32P-labeled target DNA (2 x 105 cpm). Complexes were formed in 10 mM HEPES-NaOH (pH 7.5), 5 mM MgCl2, 1 mM dithiothreitol, 5 mM KCl, 20 mM ZnCl2, 5% glycerol, and 0.1% NP-40 as described previously (39); dissolved in loading dye, 25 mM Tris-HCl (pH 7.5), 0.2% bromophenol blue, 0.2% xylene cyanol, and 4% glycerol; and resolved on a 5% polyacrylamide gel (acrylamide-bisacrylamide [37.5:1]) in low-ionic-strength gel buffer, 7 mM Tris-HCl (pH 7.5 at room temperature), 3 mM sodium acetate, and 1 mM EDTA.
| RESULTS |
|---|
|
|
|---|
As expected, RNA isolated from nontransfected NIH 3T3 cells yielded a 3-bp extension product from endogenous tRNASec molecules, whereas the primer to EGFP did not yield a product (Fig. 1, lane 1). A comparison of tRNASec expression levels arising from a plasmid carrying the entire Trsp wild-type promoter (Fig. 1, lanes 2 to 4) and a basal promoter construct (Fig. 1, lanes 5 to 7), in which all sequences upstream of the PSE are removed, shows a 37.5% decrease in tRNASec abundance. Significantly, an almost identical reduction in Trsp transcription occurs when constructs containing a mutated (Fig. 1, lanes 8 to 10) or deleted SPH element (Fig. 1, lanes 11 to 13) are transfected into NIH 3T3 cells. Similar results were obtained from studies in Swiss-3T3 fibroblasts (data not shown). Having demonstrated the important contribution that the DSE and SPH motif make to tRNASec expression in cell lines, we proceeded to examine the consequence of disrupting the DSE in vivo.
Disruption of the DSE of the Trsp locus by CR. Disruption of the DSE in vivo was achieved by inserting a floxed neomycin-thymidine kinase (positive-negative selection [PNS]) cassette between the DSE and PSE, thereby physically separating the DSE from the transcribed region of the tRNASec gene by a 3.2-kbp insertion (Fig. 2A). This technique offers the advantage that specific expression of Cre recombinase can restore tRNASec levels to normal by conditional excision of the PNS cassette (below).
Correct homologous recombination in mouse ES cells was demonstrated in two independent cell clones by PCR and Southern blotting analysis with a 5' internal and 3' external probe (Fig. 2B, lanes 2 and 3). Chimeric mice were bred onto C57BL/6, ICR, and C57BL/6/DBA mixed backgrounds to obtain heterozygous conditional rescue (Trsp+/CR) animals. These mice lines were also analyzed by Southern blotting to confirm correct transmission of the PNS cassette (Fig. 2B, lanes 5, 7, and 9).
Homozygosity for the CR locus is embryonic lethal. An initial intercross of Trsp+/CR mice on a C57BL/6 background gave 32 progeny, 11 of which were wild type, and the remaining 21 heterozygous (Table 2). Obtaining heterozygous and wild-type progeny at a ratio of ca. 2:1, and the absence of homozygous mutants suggested homozygosity for the CR locus (TrspCR/CR) was embryonic lethal. This result was reproducible when we intercrossed Trsp+/CR mice on an ICR background (results not shown).
|
The morphology of implanted embryos at E7.5 was observed by using whole-mount analyses. All embryos that displayed a normal growth rate were wild type or heterozygous, and no discernible differences were observed between these genotypes (Fig. 3A). In contrast, TrspCR/CR embryos were smaller and underdeveloped (Fig. 3A). The homozygous embryos failed to compartmentalize, although the Riechart membrane appeared to have developed at near normal rates (Fig. 3B, right-hand side). Repeated efforts were made to quantify the abundance of tRNASec in homozygous embryos but were unsuccessful most probably due to the low level of transcript. The failure of TrspCR/CR embryos to develop normally is likely due to a decrease or complete loss of certain selenoprotein species, secondary to the limited supply of tRNASec. Based on previous reports, failure to supply adequate tRNASec for UGA decoding could be expected to increase the susceptibility of selenoprotein transcript to degradation by nonsense mediated decay (NMD) (9).
|
|
Many of the selenoprotein enzymes are known to have an antioxidant function, including TR (37), GPX and SelP (43), selenoprotein W (22), and selenoprotein R (24). As such, a decrease or loss in their activity would be expected to lead to increased oxidative stress. Recently, it has been shown that conditional removal of the Trsp gene from mouse liver resulted in the induction of a GST Mu family member (6) which, it is thought, may act to counterbalance the loss of certain of the selenoprotein activities. Therefore, we examined the expression of a number of stress response enzymes in E7.5 embryos by using real-time RT-PCR (Fig. 5). The levels of GPX1 transcript in homozygous embryos was found to be 38% that of wild type (Fig. 5A) in agreement with the earlier RT-PCR analysis (Fig. 4E). The mRNA corresponding to NQO1, the glutathione-synthesizing enzyme
-glutamylcysteine synthase (data not shown) and GSTA4, were found not to increase in Trsp+/CR and TrspCR/CR embryos relative to wild-type Trsp+/+ embryos (Fig. 5B). Interestingly, in homozygous embryos the transcript levels of the heme-metabolizing enzyme HO-1 were induced 11- and 6.3-fold, respectively, compared to heterozygous and wild-type embryos (Fig. 5C).
|
Cre-mediated removal of the PNS cassette fully reestablished DSE regulation of Trsp. A key feature of the promoter targeting strategy described here is the ability to remove the PNS cassette by Cre-mediated recombination, leaving a single loxP element positioned between the DSE and PSE. Trsp+/CR mice were crossed with a transgenic line expressing Cre recombinase under the direction of an AyuI promoter. It was possible to generate mice homozygous for the rescued allele TrspR/R and mice heterozygous for the rescued allele and the CR allele TrspCR/R, as demonstrated both by PCR (Fig. 6A) and Southern blotting with a short-arm internal probe (Fig. 6B), a long-arm external probe (Fig. 6C), and a neomycin cassette probe (Fig. 6D). TrspR/R mice were viable and fertile, suggesting that removal of the PNS cassette had restored DSE regulation of tRNASec expression.
|
|
Selenoprotein mRNA and GPX1 protein levels are not affected in Trsp+/CR mice. RNA blotting analyses for the expression of selenoprotein transcript (Fig. 8A) in wild-type, TrspCR/+, and TrspR/R adult mice show that, despite significant differences in tRNASec expression, TrspCR/+ mice show no change in the mRNA level of all selenoprotein species examined in brain, liver, kidney, and heart. Antibodies generated to GPX1 were used to ascertain protein levels in the liver and kidney of wild-type, TrspCR/+, and TrspR/R mice (Fig. 8B). Again, no difference in GPX1 protein levels were found, even in kidney, where an almost 50% decrease in tRNASec was observed. These results reflect the earlier results from RT-PCR analysis of heterozygous TrspCR/+ embryos showing that reduced tRNASec levels, resulting from disruption of the DSE, does not limit selenoprotein production.
|
|
|
Interestingly, nuclear extracts from the Swiss-3T3 fibroblast and Hepa-1c1c7 hepatoma lines did not contain observable amounts of probe-binding activity (Fig. 10B, lanes 7 and 8). This correlates with the low levels of tRNASec seen in these cell lines. Further, the cell lines MH-S, L1210, and L5178, with the highest expression of tRNASec all contained the greatest abundance of probe-binding activity (Fig. 10B, lanes 10 to 12). An exception among the lines investigated was the P815 line, for although comparatively high binding activity for the DSE probe was observed (Fig. 10B, lane 9), the tRNASec levels were the lowest of all lines examined (Fig. 10A, lane 5). Intriguingly, two previously unreported complexes were also found to bind to the DSE probe in the lymphoblastic lines, shown as bands 2 and 3 (Fig. 10B, lanes 11 and 12), the identity of which is unknown. Binding studies performed by using mutated cold probes demonstrated that the additional protein complexes had the ability to bind the DSE template independently of the Staf containing complex and, conversely, that Staf was capable of interacting with the probe in the absence of the additional factors (data not shown).
It is possible that the differential probe-binding activity of each cell line arises from the variable expression of the Staf transcription factor. Therefore, RNA blotting was performed to quantify Staf transcript abundance (Fig. 10C). Comparable levels of message were observed in all cell lines, suggesting that Staf transcript abundance alone could not account for the notable differences in probe-binding activity. Similarly, in mouse tissue samples the levels of Staf message did not correlate with tRNASec expression (data not shown).
| DISCUSSION |
|---|
|
|
|---|
The DSE is a tissue-specific enhancer of tRNASec transcription. Early studies on the transcriptional regulation of the Xenopus tRNASec gene identified a 15-bp SPH element within the DSE region, which when mutated resulted in a 20-fold drop in transcriptional activity (5, 34). It was found that the SPH element functions independently of other transcription elements, including an octamer or Sph1 motif, elements commonly associated with the SPH of the snRNA and snRNA-type genes (34, 38).
Our initial transfection studies in NIH 3T3 cells resulted in a comparatively modest decrease (38%) in tRNASec expression upon deletion of the DSE. This could arguably result from differences in the relative contribution of the DSE to the expression of the mouse and Xenopus Trsp genes. However, our data suggest that the role of the DSE in Trsp transcription may be more complex. In animals, heterozygous disruption of the DSE resulted in a highly variable decrease in tRNASec levels between each of the tissues examined. For example, in the kidney of heterozygous animals tRNASec abundance dropped to 50% that of wild type, whereas in heart no decrease occurred. Therefore, we hypothesize that the regulation of tRNASec transcription through the DSE is tissue specific. We found that, in support of this conclusion, the abundance of tRNASec also varied greatly between eight different cell lines, and we could show that tRNASec levels, in all but one case, corresponded to the binding activity to the DSE.
Unlike Xenopus, the tRNASec gene promoters of mice and humans both contain an octamer sequence immediately downstream of the SPH motif of sequence ATGCAAAT and ATGTAAAT, respectively. The results of our experiments suggest that the octamer motif makes a relatively small contribution, if any, to the regulation of the mouse Trsp gene. Specific mutation or deletion of the SPH motif alone gave an almost identical drop in tRNASec expression to complete removal of the DSE region. The relative importance of individual motifs within the DSE and the possibility that species differences exist in tRNASec gene regulation awaits further investigation.
Gene rescue experiments by Cre-induced recombination revealed that tRNASec expression could be restored to normal by removal of the PNS cassette, leaving a single loxP element inserted between the DSE and PSE. Clearly, this shift in the position of the DSE relative to the tRNASec transcription unit fails to impact on transcription of the Trsp gene. This is in agreement with earlier studies on the Xenopus tRNASec gene that showed the SPH motif can be flipped or moved upstream or downstream of its normal position and still retain activity (34).
DSE regulation of tRNASec transcription is essential for mouse development. The targeting method in the present study describes for the first time the use of a CR strategy in the analysis of an RNA polymerase III transcribed gene. Disruption of the DSE by CR proved successful since TrspCR/CR mice were underdeveloped and smaller than their wild-type and heterozygous counterparts and died during development preceding gastrulation, at approximately E7.5. This finding is in contrast to Trsp-null mutant mice, which die significantly earlier, around the peri-implantation stage, at E4.5 (4). Thus, disruption of the DSE has a milder phenotype compared to deletion of the tRNASec gene.
An entire protein family of selenoenzymes relies upon the tRNASec molecule for expression; therefore, the embryonic lethality of Trsp-targeted mice could be ascribed to the loss any one or a combination of these proteins. Given that the TrspCR/CR and Trsp/ mice die at unrelated stages of development, it is quite probable that a different selenoenzyme(s) accounts for the lethality. As such, two distinct blocks to development occur in the absence or limited supply of tRNASec.
In the case of Trsp/ animals, the loss of TR activity could contribute to the block to early embryogenesis. TR, along with its thiol-protein substrate thioredoxin, are linked to several important antioxidant and redox regulatory systems within the cell including the synthesis of deoxyribonucleotides, the regulation of several transcription factors, and the activity of protein kinases (32). Significantly, similar to Trsp/ mice, knockout mice for the thioredoxin gene die at the peri-implantation stage (27). The conditional repair strategy described in the present study allowed the embryo to bypass this initial block to reveal a second block to development occurring pregastrulation.
To date, the genes encoding five members of the selenoprotein family have been disrupted in mice: GPX1 (7), GPX2 (10), GPX4 (17, 46), DIO2 (40), and SelP (16). Of these, only GPX4 knockout mice were embryonic lethal, dying in utero at the pregastrulation stage. Notably, this is similar to the TrspCR/CR mice. Indeed, both TrspCR/CR and Gpx4/ homozygous embryos are discernible by their lack of normal structural compartmentalization (46). Interestingly, RT-PCR analysis of GPX4 mRNA in wild-type mouse embryos suggests that GPX4 message is not expressed in the embryo proper. Previous immunohistochemical studies of E7.5 embryos with antibodies to GPX4 detected protein expression in the ectoderm and yolk sac (17). These results attest to the necessity of appropriate temporal and spatial synthesis of tRNASec in the early embryo to allow sufficient production of essential selenoenzymes.
TrspCR/CR mice show a differential decrease in selenoprotein transcript levels. An investigation of selenoprotein transcript levels in E7.5 embryos showed that in mice heterozygous for the CR allele, sufficient tRNASec levels were present to maintain normal production of selenoenzyme message. Similarly, in the brains, livers, kidneys, and hearts of adult Trsp+/CR mice no changes in the levels of RNA message for any of the selenoprotein species studied were observed, nor was there any change in GPX1 protein levels observed in adult livers and kidneys. This is in spite of drop of 50% in tRNASec levels seen in the kidney. These results agree with previous reports demonstrating heterozygous levels of tRNASec are not limiting for selenoprotein production under normal laboratory conditions (4, 6).
By producing TrspCR/CR mice we had the opportunity to study the impact of decreasing tRNASec levels below those of heterozygous-null mice. We observed a large decrease in SelP and DIO1 mRNA abundance, an intermediate decrease in the case of GPX1 and a less-pronounced change in TR1 mRNA in TrspCR/CR mice relative to wild-type and heterozygous embryos. Therefore, the lower levels of tRNASec in TrspCR/CR mice leads to a differential decay in selenoprotein message. The hierarchy of selenoprotein stability observed in the current study differs somewhat from studies in which animals were deprived of selenium (15, 44), where the largest decreases were found in the GPX1 message. This may be explained by the observation that GPX1 message is actively degraded by NMD, whereas other selenoprotein members appear largely resistant to such effects (29, 42, 45). A loss or decrease in tRNASec may highlight alternative factors which are not observed during conditions of low dietary selenium that promote a differential decrease in selenoprotein transcript.
The results from TrspCR/CR mice also contrast somewhat with those obtained upon conditional removal of Trsp in mouse livers. In the latter case, the levels of GPX1 and SelP message were reduced but those of GPX4, DIO1, and TR1 were similar in abundance to those in heterozygous mice (6). It is possible that tissue-specific factors are involved in the preferential decay of selenoprotein mRNA that could account for the differences seen in Trsp/ liver and TrspCR/CR embryos. For example, it has been reported previously that although GPX4 is susceptible to NMD in mouse fibroblasts and rat hepatoma cell lines, in the liver and testis an uncharacterized mechanism exists to mask GPX4 mRNA from NMD (42).
Surprisingly, the abundance of mRNA coding for the DIO2 enzyme is not affected in TrspCR/CR mice, possibly reflecting an important role for this enzyme in embryonic development. Circulating thyroid hormone is inactivated by inner-ring deiodination through the activity of the selenoprotein DIO3. This enzyme acts as a barrier to the passage of maternal thyroid hormone, since it is highly expressed in placenta, amnion, uterus, and particularly at the site of implantation (2). The fetal expression of DIO2 may serve as a local source of active thyroid hormone.
HO-1 mRNA levels are elevated in TrspCR/CR embryos. In a recent report, conditional removal of the Trsp gene from liver was shown to induce the expression of a GST Mu family member (6). Likewise, rats that were made to be selenium deficient showed a large increase in the protein levels of GST class Alpha, Mu, and Theta and of the aldo-keto reductase 7A1 in the liver (28). It is expected that the induction of these proteins may compensate for the loss of protective antioxidant properties of the selenoproteins.
Numerous studies have documented the induction of GST enzymes, including the Mu class, in response to oxidative stress or chemical insults and shown it depends on a cis-acting DNA regulatory element known as the antioxidant response element (ARE) and its cognate transcription factor Nrf2 (12). A common feature is the ability of inducing agents to increase the intercellular oxidative stress such as would be expected to occur in the absence of selenoproteins. Apart from GST members, other detoxification and antioxidant enzymes known to rely on the Nrf2 stress response pathway include NQO1,
-glutamylcysteine synthase, and HO-1 (12, 13).
Therefore, we examined the expression of stress enzymes in TrspCR/CR embryos and were surprised to find that the levels of GSTA4, NQO1, and GCLC were unchanged relative to the wild type. This prompted us to examine the expression of Nrf2 transcript. Previous reports on mice carrying a gene deletion of Nrf2 showed that, in the absence of Nrf2, ARE genes were not induced by a range of agents known to cause oxidative stress (20, 35). No Nrf2 transcript could be detected in E7.5 embryos, providing a possible explanation of why TrspCR/CR embryos fail to mount a protective antioxidant response. Indeed, the inability to respond to alterations in the redox environment could mean that early development is particularly sensitive to damage caused by reactive oxygen species.
Intriguingly, in contrast to other antioxidant enzymes the mRNA transcript for HO-1 was found to be markedly elevated in TrspCR/CR animals, presumably through an Nrf2 independent mechanism. Previous reports have shown that selenium deficiency in rats increases the expression of HO-1 in liver and by using inhibitors it was possible to demonstrate that the loss of TR activity was responsible for the induction (30). HO-1 induction would be expected to enhance the antioxidant status of the cell by virtue of HO-1 ability to catabolize heme into carbon monoxide, biliverdin, and free iron. Each of these products, either directly or indirectly, has been shown to be protective in rodent models of oxidative damage and inflammation, such as ischemia-reperfusion injury and xenograft survival (36).
Concluding remarks. An important feature of the present targeting strategy was the ability to restore tRNASec expression to normal by the coexpression of Cre recombinase. It is hoped that by crossing the mice described here with strains expressing Cre recombinase in various embryonic layers, it will be possible to overcome the lethality at pregastrulation. In this way it may be possible to gain further insight into the role of the selenoenzymes during embryogenesis and development.
| ACKNOWLEDGMENTS |
|---|
This study was supported by grants from ERATO-JST; the Ministry of Education, Science, Sports, and Culture; the Ministry of Health, Labor, and Welfare; and the Atherosclerosis Foundation.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Bianco, A. C., D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen. 2002. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocrinol. Rev. 23:38-89.
3. Bosl, M. R., M. F. Seldin, S. Nishimura, and M. Taketo. 1995. Cloning, structural analysis and mapping of the mouse selenocysteine tRNA([Ser]Sec) gene (Trsp). Mol. Gen. Genet. 248:247-252.[CrossRef][Medline]
4. Bosl, M. R., K. Takaku, M. Oshima, S. Nishimura, and M. M. Taketo. 1997. Early embryonic lethality caused by targeted disruption of the mouse selenocysteine tRNA gene (Trsp). Proc. Natl. Acad. Sci. USA 94:5531-5534.
5. Carbon, P., and A. Krol. 1991. Transcription of the Xenopus laevis selenocysteine tRNA(Ser)Sec gene: a system that combines an internal B box and upstream elements also found in U6 snRNA genes. EMBO J. 10:599-606.[Medline]
6. Carlson, B. A., S. V. Novoselov, E. Kumaraswamy, B. J. Lee, M. R. Anver, V. N. Gladyshev, and D. L. Hatfield. 2004. Specific excision of the selenocysteine tRNA[Ser]Sec (Trsp) gene in mouse liver demonstrates an essential role of selenoproteins in liver function. J. Biol. Chem. 279:8011-8017.
7. Cheng, W. H., Y. S. Ho, D. A. Ross, B. A. Valentine, G. F. Combs, and X. G. Lei. 1997. Cellular glutathione peroxidase knockout mice express normal levels of selenium-dependent plasma and phospholipid hydroperoxide glutathione peroxidases in various tissues. J. Nutr. 127:1445-1450.
8. Copeland, P. R. 2003. Regulation of gene expression by stop codon recoding: selenocysteine. Gene 312:17-25.[CrossRef][Medline]
9. Driscoll, D. M., and P. R. Copeland. 2003. Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23:17-40.[CrossRef][Medline]
10. Esworthy, R. S., R. Aranda, M. G. Martin, J. H. Doroshow, S. W. Binder, and F. F. Chu. 2001. Mice with combined disruption of Gpx1 and Gpx2 genes have colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G848-G855.
11. Hatfield, D. L., and V. N. Gladyshev. 2002. How selenium has altered our understanding of the genetic code. Mol. Cell. Biol. 22:3565-3576.
12. Hayes, J. D., J. U. Flanagan, and I. R. Jowsey. 2005. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45:51-88.[CrossRef][Medline]
13. Hayes, J. D., and M. McMahon. 2001. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer Lett. 174:103-113.[CrossRef][Medline]
14. Hernandez, N. 2001. Small nuclear RNA genes: a model system to study fundamental mechanisms of transcription. J. Biol. Chem. 276:26733-26736.
15. Hill, K. E., P. R. Lyons, and R. F. Burk. 1992. Differential regulation of rat liver selenoprotein mRNAs in selenium deficiency. Biochem. Biophys. Res. Commun. 185:260-263.[CrossRef][Medline]
16. Hill, K. E., J. Zhou, W. J. McMahan, A. K. Motley, J. F. Atkins, R. F. Gesteland, and R. F. Burk. 2003. Deletion of selenoprotein P alters distribution of selenium in the mouse. J. Biol. Chem. 278:13640-13646.
17. Imai, H., F. Hirao, T. Sakamoto, K. Sekine, Y. Mizukura, M. Saito, T. Kitamoto, M. Hayasaka, K. Hanaoka, and Y. Nakagawa. 2003. Early embryonic lethality caused by targeted disruption of the mouse PHGPx gene. Biochem. Biophys. Res. Commun. 305:278-286.[CrossRef][Medline]
18. Immenschuh, S., and G. Ramadori. 2000. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem. Pharmacol. 60:1121-1128.[CrossRef][Medline]
19. Ishii, T., K. Itoh, E. Ruiz, D. S. Leake, H. Unoki, M. Yamamoto, and G. E. Mann. 2004. Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal. Circ. Res. 94:609-616.
20. Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313-322.[CrossRef][Medline]
21. Itoh, K., M. Mochizuki, Y. Ishii, T. Ishii, T. Shibata, Y. Kawamoto, V. Kelly, K. Sekizawa, K. Uchida, and M. Yamamoto. 2004. Transcription factor Nrf2 regulates inflammation by mediating the effect of 15-deoxy-
(12,14)-prostaglandin j(2). Mol. Cell. Biol. 24:36-45.
22. Jeong, D., T. S. Kim, Y. W. Chung, B. J. Lee, and I. Y. Kim. 2002. Selenoprotein W is a glutathione-dependent antioxidant in vivo. FEBS Lett. 517:225-228.[CrossRef][Medline]
23. Kelly, V. P., P. J. Sherratt, D. H. Crouch, and J. D. Hayes. 2002. Novel homodimeric and heterodimeric rat gamma-hydroxybutyrate synthases that associate with the Golgi apparatus define a distinct subclass of aldo-keto reductase 7 family proteins. Biochem. J. 366:847-861.[Medline]
24. Kryukov, G. V., R. A. Kumar, A. Koc, Z. Sun, and V. N. Gladyshev. 2002. Selenoprotein R is a zinc-containing stereo-specific methionine sulfoxide reductase. Proc. Natl. Acad. Sci. USA 99:4245-4250.
25. Kryukov, G. V., S. Castellano, S. V. Novoselov, A. V. Lobanov, O. Zehtab, R. Guigo, and V. N. Gladyshev. 2003. Characterization of mammalian selenoproteomes. Science 300:1439-1443.
26. Lambert, A., A. Lescure, and D. Gautheret. 2002. A survey of metazoan selenocysteine insertion sequences. Biochimie 84:953-959.[Medline]
27. Matsui, M., M. Oshima, H. Oshima, K. Takaku, T. Maruyama, J. Yodoi, and M. M. Taketo. 1996. Early embryonic lethality caused by targeted disruption of the mouse thioredoxin gene. Dev. Biol. 178:179-185.[CrossRef][Medline]
28. McLeod, R., E. M. Ellis, J. R. Arthur, G. E. Neal, D. J. Judah, M. M. Manson, and J. D. Hayes. 1997. Protection conferred by selenium deficiency against aflatoxin B1 in the rat is associated with the hepatic expression of an aldo-keto reductase and a glutathione S-transferase subunit that metabolize the mycotoxin. Cancer Res. 57:4257-4266.
29. Moriarty, P. M., C. C. Reddy, and L. E. Maquat. 1998. Selenium deficiency reduces the abundance of mRNA for Se-dependent glutathione peroxidase 1 by a UGA-dependent mechanism likely to be nonsense codon-mediated decay of cytoplasmic mRNA. Mol. Cell. Biol. 18:2932-2939.
30. Mostert, V., K. E. Hill, and R. F. Burk. 2003. Loss of activity of the selenoenzyme thioredoxin reductase causes induction of hepatic heme oxygenase-1. FEBS Lett. 541:85-88.[CrossRef][Medline]
31. Moustafa, M. E., B. A. Carlson, M. A. El-Saadani, G. V. Kryukov, Q. A. Sun, J. W. Harney, K. E. Hill, G. F. Combs, L. Feigenbaum, D. B. Mansur, R. F. Burk, M. J. Berry, A. M. Diamond, B. J. Lee, V. N. Gladyshev, and D. L. Hatfield. 2001. Selective inhibition of selenocysteine tRNA maturation and selenoprotein synthesis in transgenic mice expressing isopentenyladenosine-deficient selenocysteine tRNA. Mol. Cell. Biol. 21:3840-3852.
32. Mustacich, D., and G. Powis. 2000. Thioredoxin reductase. Biochem. J. 346:1-8.
33. Myslinski, E., A. Krol, and P. Carbon. 1998. ZNF76 and ZNF143 are two human homologs of the transcriptional activator Staf. J. Biol. Chem. 273:21998-22006.
34. Myslinski, E., A. Krol, and P. Carbon. 1992. Optimal tRNA((Ser)Sec) gene activity requires an upstream SPH motif. Nucleic Acids Res. 20:203-209.
35. Nguyen, T., P. J. Sherratt, and C. B. Pickett. 2003. Regulatory mechanisms controlling gene expression mediated by the antioxidant response element. Annu. Rev. Pharmacol. Toxicol. 43:233-260.[CrossRef][Medline]
36. Otterbein, L. E., M. P. Soares, K. Yamashita, and F. H. Bach. 2003. Heme oxygenase-1: unleashing the protective properties of heme. Trends Immunol. 24:449-455.[CrossRef][Medline]
37. Powis, G., D. Mustacich, and A. Coon. 2000. The role of the redox protein thioredoxin in cell growth and cancer. Free Radic. Biol. Med. 29:312-322.[CrossRef][Medline]
38. Schaub, M., E. Myslinski, C. Schuster, A. Krol, and P. Carbon. 1997. Staf, a promiscuous activator for enhanced transcription by RNA polymerases II and III. EMBO J. 16:173-181.[CrossRef][Medline]
39. Schaub, M., A. Krol, and P. Carbon. 2000. Structural organization of Staf-DNA complexes. Nucleic Acids Res. 28:2114-2121.
40. Schneider, M. J., S. N. Fiering, S. E. Pallud, A. F. Parlow, D. L. St. Germain, and V. A. Galton. 2001. Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol. Endocrinol. 15:2137-2148.
41. Schuster, C., E. Myslinski, A. Krol, and P. Carbon. 1995. Staf, a novel zinc finger protein that activates the RNA polymerase III promoter of the selenocysteine tRNA gene. EMBO J. 14:3777-3787.[Medline]
42. Sun, X., X. Li, P. M. Moriarty, T. Henics, J. P. LaDuca, and L. E. Maquat. 2001. Nonsense-mediated decay of mRNA for the selenoprotein phospholipid hydroperoxide glutathione peroxidase is detectable in cultured cells but masked or inhibited in rat tissues. Mol. Biol. Cell 12:1009-1017.
43. Takebe, G., J. Yarimizu, Y. Saito, T. Hayashi, H. Nakamura, J. Yodoi, S. Nagasawa, and K. Takahashi. 2002. A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P. J. Biol. Chem. 277:41254-41258.
44. Weiss Sachdev, S., and R. A. Sunde. 2001. Selenium regulation of transcript abundance and translational efficiency of glutathione peroxidase-1 and -4 in rat liver. Biochem. J. 357:851-858.[CrossRef][Medline]
45. Wingler, K., M. Bocher, L. Flohe, H. Kollmus, and R. Brigelius-Flohe. 1999. mRNA stability and selenocysteine insertion sequence efficiency rank gastrointestinal glutathione peroxidase high in the hierarchy of selenoproteins. Eur. J. Biochem. 259:149-157.[Medline]
46. Yant, L. J., Q. Ran, L. Rao, H. Van Remmen, T. Shibatani, J. G. Belter, L. Motta, A. Richardson, and T. A. Prolla. 2003. The selenoprotein GPX4 is essential for mouse development and protects from radiation and oxidative damage insults. Free Radic. Biol. Med. 34:496-502.[CrossRef][Medline]
| |||||||||||||||||||||||||||||||||